Conversations on 
Twitter :
 |
|
|
|
|
|
|
@FierceBiotech: Bedside blood infection test being developed for sepsis. Item | Follow @FierceBiotech
@JohnCFierce: Interesting: J&J setting up 4 deal teams around the globe - Boston. California. China and London. Via Reuters: Report | Follow @JohnCFierce
@RyanMFierce: Fierce 15 arrives tomorrow. Here are some details on what to expect: More | Follow @RyanMFierce
> Merck KGaA has yanked its second application to use Erbitux as a treatment for lung cancer. The pharma company says that European regulators had made it clear that they would need to see more data before it could be approved. Story
> Shares of Ablynx got a bump on the news that its early-stage inhaled antibody therapy for RSV delivered positive results in a Phase I study. Story
> Shares of Anthera Pharmaceuticals ($ANTH) jumped on the news that it is preparing a late-stage trial for its lupus drug blisibimod. Story
> Australia's Biota has altered the terms on its proposed reverse merger with Nabi, leaving its investors with a larger share of the combined operation while shrinking the amount of cash that will be available. Story
> Mutabilis has snagged 4 million euros of European funding for the HIVINNOV project, which is aimed at developing new antiretrovirals against HIV. Release
Pharma News
@FiercePharma: WSJ's story on the Chinese drug-price cuts: Report | Follow @FiercePharma
> Analysts eye generic threat as Vivus rolls out Qsymia. Article
> Merck yanks European app for Erbitux in lung cancer. Story
> Costly cancer drugs get the Chinese price-cutting treatment. More
@FierceMedDev: BioFire Diagnostics pulls in $25M in new funding for accelerated product development. Release | Follow @FierceMedDev
@MarkHFierce: The iPhone 5 could accelerate the migration of medical devices to Bluetooth, eWeek reports. More | Follow @MarkHFierce
@DamianFierce: Medtronic is looking to pair its pump technology with the next generation of Alzheimer's drugs. Report | Follow @DamianFierce
> J&J plans innovation centers, looking for buys and team-ups. Story
> Navidea launches PhII for Alzheimer's imaging. News
Pharma Manufacturing News
> Gelatin prices look to rise steeply. Story
> Boehringer Ingelheim closing 1 of 3 U.S. API plants. More
> India says it will meet EU's API quality deadline. Report
Biotech Research News
> Mayo Clinic spies enzyme that destroys brain-clogging Alzheimer's protein. More
> Drug combo packs punch fighting rare form of melanoma in mice. Story
> UMass sensor array 'smelled' metastatic cancer cells in preclinical study. Article
And Finally… Researchers at the Karolinska Institutet say they have identified a substance--APR-246--that can restore defective p53 genes and enhance apoptosis in cancer therapy. The drug was used to treat a small group of patients. Story